These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17474891)
1. An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations. Cooper PC; Rezende SM Int J Lab Hematol; 2007 Jun; 29(3):153-62. PubMed ID: 17474891 [TBL] [Abstract][Full Text] [Related]
2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR. Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382 [TBL] [Abstract][Full Text] [Related]
4. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study. Chaireti R; Jennersjö C; Lindahl TL Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683 [TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A]. Reitsma PH; van de Stolpe A Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction. Cooper PC; Cooper SM; Smith JM; Kitchen S; Makris M Blood Coagul Fibrinolysis; 2003 Jul; 14(5):499-503. PubMed ID: 12851538 [TBL] [Abstract][Full Text] [Related]
7. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D; Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889 [TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601 [TBL] [Abstract][Full Text] [Related]
9. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388 [TBL] [Abstract][Full Text] [Related]
10. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis. Gessoni G; Valverde S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197 [TBL] [Abstract][Full Text] [Related]
13. A whole blood, multiplex PCR detection method for factor V Leiden and the prothrombin G20210A variant. Keeney S; Salden A; Hay C; Cumming A Thromb Haemost; 1999 Mar; 81(3):464-5. PubMed ID: 10102480 [No Abstract] [Full Text] [Related]
14. Venous thromboembolism: implications for gene-based diagnosis and technology development. Hooper WC; De Staercke C Expert Rev Mol Diagn; 2002 Nov; 2(6):576-86. PubMed ID: 12465454 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931 [TBL] [Abstract][Full Text] [Related]
16. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations. Koksal V; Baris I; Etlik O Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729 [TBL] [Abstract][Full Text] [Related]
18. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism]. Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367 [TBL] [Abstract][Full Text] [Related]
19. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854 [TBL] [Abstract][Full Text] [Related]
20. [Genetic risk factors of venous thromboembolism]. Oner F; Kaya A; Doğan R; Numanoğlu N Tuberk Toraks; 2003; 51(1):60-9. PubMed ID: 15100907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]